50% Of Proceeds From Subscriptions To Benefit Games For Change New offerings combine a variety of Medidata technologies and learnings from thousands of previous trials to streamline study management for Phase II and Phase III studies in specified therapeutic areas, reinforcing FDA guidance for patient-centered study design and executionXsolla and Long Tale Games Launch Charity Campaign With Life Is Feudal to Support Games for Change
Medidata Launches Bundled Solutions to Support Oncology and Vaccine Trials, Accelerating Study Design and Execution
| ABX | ||
| 3,574.873 | ||
| -149.6450 | -0.0402% | |
| BISNIS-27 | ||
| 534.439 | ||
| 10.5120 | 0.0201% | |
| DBX | ||
| 4,004.792 | ||
| 37.8180 | 0.0095% | |
| ECONOMIC30 | ||
| 114.452 | ||
| 2.2500 | 0.0201% | |
| ESGQKEHATI | ||
| 124.717 | ||
| 2.4960 | 0.0204% | |
| ESGSKEHATI | ||
| 125.220 | ||
| 2.6580 | 0.0217% | |
| I-GRADE | ||
| 217.340 | ||
| 4.8850 | 0.0230% | |
| AUDRP | ||
| 11,745.560 | ||
| -58.7000 | -0.4973% | |
| EURRP | ||
| 19,989.270 | ||
| -56.2200 | -0.2805% | |
| JPYRP | ||
| 108.864 | ||
| -0.5016 | -0.4586% | |
| SINRP | ||
| 13,222.650 | ||
| -10.0600 | -0.0760% | |
| USDRP | ||
| 16,765.000 | ||
| 19.0000 | 0.1135% | |
